• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

EphA3介导的白血病前期胸腺细胞外分化阻滞促进疾病进展。

Cell-Extrinsic Differentiation Block Mediated by EphA3 in Pre-Leukaemic Thymus Contributes to Disease Progression.

作者信息

Pliego Zamora Adriana C, Ranasinghe Hansini, Lisle Jessica E, Ng Chun Ki, Huang Stephen, Wadlow Racheal, Scott Andrew M, Boyd Andrew W, Slape Christopher I

机构信息

The University of Queensland Diamantina Institute, The University of Queensland, Brisbane 4102, Australia.

Olivia Newton-John Cancer Research Institute and La Trobe University, Heidelberg 3084, Australia.

出版信息

Cancers (Basel). 2021 Jul 31;13(15):3858. doi: 10.3390/cancers13153858.

DOI:10.3390/cancers13153858
PMID:34359759
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8345401/
Abstract

We recently characterised the () mouse as a model of T-cell pre-leukaemia, featuring thymocytes that can engraft in recipient animals and progress to T-cell acute lymphoblastic leukaemia (T-ALL). However, loss of this engraftment ability by deletion of did not result in any loss of leukemogenesis activity. In the present study, we observe that thymocytes overexpress EPHA3, and we characterise thymocyte behaviour in mice with deletion of , which show a markedly reduced incidence of T-ALL. Deletion of from the mice does not prevent the abnormal accumulation or transplantation ability of these thymocytes. However, upon transplantation, these cells are unable to block the normal progression of recipient wild type (WT) progenitor cells through the normal developmental pathway. This is in contrast to the   thymocytes, which block the progression of incoming WT progenitors past the DN1 stage. Therefore, is not critical for classical self-renewal, but is essential for mediating an interaction between the abnormally self-renewing cells and healthy progenitors-an interaction that results in a failure of the healthy cells to differentiate normally. We speculate that this may orchestrate a loss of healthy cell competition, which in itself has been demonstrated to be oncogenic, and that this may explain the decrease in T-ALL incidence in the absence of . We suggest that pre-leukaemic self-renewal in this model is a complex interplay of cell-intrinsic and -extrinsic factors, and that multiple redundant pathways to leukaemogenesis are active.

摘要

我们最近将()小鼠鉴定为T细胞白血病前期模型,其特征是胸腺细胞能够植入受体动物体内并发展为T细胞急性淋巴细胞白血病(T-ALL)。然而,通过缺失()来丧失这种植入能力并未导致白血病发生活性的任何丧失。在本研究中,我们观察到()胸腺细胞过表达EPHA3,并且我们对缺失()的()小鼠中的胸腺细胞行为进行了表征,这些小鼠显示T-ALL的发病率显著降低。从()小鼠中缺失()并不能阻止这些胸腺细胞的异常积累或移植能力。然而,在移植后,这些细胞无法阻止受体野生型(WT)祖细胞通过正常发育途径的正常进展。这与()胸腺细胞形成对比,后者会阻止进入的WT祖细胞越过DN1阶段的进展。因此,()对于经典的自我更新并不关键,但对于介导异常自我更新的细胞与健康祖细胞之间的相互作用至关重要——这种相互作用导致健康细胞无法正常分化。我们推测,这可能会导致健康细胞竞争的丧失,而健康细胞竞争本身已被证明具有致癌性,这可能解释了在没有()的情况下T-ALL发病率的降低。我们认为,该模型中白血病前期的自我更新是细胞内在和外在因素的复杂相互作用,并且多种冗余的白血病发生途径是活跃的。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3483/8345401/7df35628f1dc/cancers-13-03858-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3483/8345401/2360e51c7fc8/cancers-13-03858-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3483/8345401/869359205f1a/cancers-13-03858-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3483/8345401/4a8240bba903/cancers-13-03858-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3483/8345401/e2e930d6230c/cancers-13-03858-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3483/8345401/033aa8975e03/cancers-13-03858-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3483/8345401/7df35628f1dc/cancers-13-03858-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3483/8345401/2360e51c7fc8/cancers-13-03858-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3483/8345401/869359205f1a/cancers-13-03858-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3483/8345401/4a8240bba903/cancers-13-03858-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3483/8345401/e2e930d6230c/cancers-13-03858-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3483/8345401/033aa8975e03/cancers-13-03858-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3483/8345401/7df35628f1dc/cancers-13-03858-g006.jpg

相似文献

1
Cell-Extrinsic Differentiation Block Mediated by EphA3 in Pre-Leukaemic Thymus Contributes to Disease Progression.EphA3介导的白血病前期胸腺细胞外分化阻滞促进疾病进展。
Cancers (Basel). 2021 Jul 31;13(15):3858. doi: 10.3390/cancers13153858.
2
The NUP98-HOXD13 fusion oncogene induces thymocyte self-renewal via Lmo2/Lyl1.NUP98-HOXD13 融合癌基因通过 Lmo2/Lyl1 诱导胸腺细胞自我更新。
Leukemia. 2019 Aug;33(8):1868-1880. doi: 10.1038/s41375-018-0361-0. Epub 2019 Jan 30.
3
Thymic precursor cells generate acute myeloid leukemia in NUP98-PHF23/NUP98-HOXD13 double transgenic mice.胸腺前体细胞在 NUP98-PHF23/NUP98-HOXD13 双转基因小鼠中产生急性髓系白血病。
Sci Rep. 2019 Nov 20;9(1):17213. doi: 10.1038/s41598-019-53610-7.
4
SCL, LMO1 and Notch1 reprogram thymocytes into self-renewing cells.SCL、LMO1和Notch1将胸腺细胞重编程为自我更新细胞。
PLoS Genet. 2014 Dec 18;10(12):e1004768. doi: 10.1371/journal.pgen.1004768. eCollection 2014 Dec.
5
Thymocytes self-renewal: a major hope or a major threat?胸腺细胞自我更新:是主要希望还是主要威胁?
Immunol Rev. 2016 May;271(1):173-84. doi: 10.1111/imr.12408.
6
Loss of thymocyte competition underlies the tumor suppressive functions of the E2a transcription factor in T lymphocyte acute lymphoblastic leukemia.胸腺细胞竞争的丧失是E2a转录因子在T淋巴细胞急性淋巴细胞白血病中发挥肿瘤抑制功能的基础。
bioRxiv. 2023 Apr 25:2023.04.23.537993. doi: 10.1101/2023.04.23.537993.
7
Targeting of the bone marrow microenvironment improves outcome in a murine model of myelodysplastic syndrome.靶向骨髓微环境可改善骨髓增生异常综合征小鼠模型的预后。
Blood. 2016 Feb 4;127(5):616-25. doi: 10.1182/blood-2015-06-653113. Epub 2015 Dec 4.
8
BOK promotes erythropoiesis in a mouse model of myelodysplastic syndrome.BOK 在骨髓增生异常综合征的小鼠模型中促进红细胞生成。
Ann Hematol. 2019 Sep;98(9):2089-2096. doi: 10.1007/s00277-019-03726-7. Epub 2019 Jun 16.
9
Altered follicular helper T cell impaired antibody production in a murine model of myelodysplastic syndromes.在骨髓增生异常综合征小鼠模型中,滤泡辅助性T细胞改变导致抗体产生受损。
Oncotarget. 2017 Oct 6;8(58):98270-98279. doi: 10.18632/oncotarget.21548. eCollection 2017 Nov 17.
10
Hypoxia-controlled EphA3 marks a human endometrium-derived multipotent mesenchymal stromal cell that supports vascular growth.缺氧调控的EphA3标记一种支持血管生长的人子宫内膜来源的多能间充质基质细胞。
PLoS One. 2014 Nov 24;9(11):e112106. doi: 10.1371/journal.pone.0112106. eCollection 2014.

引用本文的文献

1
EPHA3 Could Be a Novel Prognosis Biomarker and Correlates with Immune Infiltrates in Bladder Cancer.EPHA3可能是一种新型的预后生物标志物,且与膀胱癌中的免疫浸润相关。
Cancers (Basel). 2023 Jan 19;15(3):621. doi: 10.3390/cancers15030621.

本文引用的文献

1
The Role of the Eph Receptor Family in Tumorigenesis.Eph受体家族在肿瘤发生中的作用。
Cancers (Basel). 2021 Jan 8;13(2):206. doi: 10.3390/cancers13020206.
2
Eph Receptors in the Immunosuppressive Tumor Microenvironment.Eph 受体在免疫抑制性肿瘤微环境中的作用。
Cancer Res. 2021 Feb 15;81(4):801-805. doi: 10.1158/0008-5472.CAN-20-3047. Epub 2020 Nov 11.
3
Antibody Targeting of Eph Receptors in Cancer.癌症中Eph受体的抗体靶向作用
Pharmaceuticals (Basel). 2020 May 8;13(5):88. doi: 10.3390/ph13050088.
4
The NUP98-HOXD13 fusion oncogene induces thymocyte self-renewal via Lmo2/Lyl1.NUP98-HOXD13 融合癌基因通过 Lmo2/Lyl1 诱导胸腺细胞自我更新。
Leukemia. 2019 Aug;33(8):1868-1880. doi: 10.1038/s41375-018-0361-0. Epub 2019 Jan 30.
5
T Cell Acute Lymphoblastic Leukemia as a Consequence of Thymus Autonomy.T 细胞急性淋巴细胞白血病是胸腺自主性的结果。
J Immunol. 2019 Feb 15;202(4):1137-1144. doi: 10.4049/jimmunol.1801373. Epub 2019 Jan 16.
6
EphA3 Pay-Loaded Antibody Therapeutics for the Treatment of Glioblastoma.用于治疗胶质母细胞瘤的携带EphA3的抗体疗法
Cancers (Basel). 2018 Dec 17;10(12):519. doi: 10.3390/cancers10120519.
7
Normal epithelial cells trigger EphA2-dependent RasV12 cell repulsion at the single cell level.正常上皮细胞在单细胞水平触发EphA2依赖性的RasV12细胞排斥。
Small GTPases. 2019 Jul;10(4):305-310. doi: 10.1080/21541248.2017.1324940. Epub 2017 Jun 21.
8
Epha3 acts as proangiogenic factor in multiple myeloma.Epha3在多发性骨髓瘤中作为促血管生成因子发挥作用。
Oncotarget. 2017 May 23;8(21):34298-34309. doi: 10.18632/oncotarget.16100.
9
The genetics and molecular biology of T-ALL.T 细胞急性淋巴细胞白血病的遗传学与分子生物学
Blood. 2017 Mar 2;129(9):1113-1123. doi: 10.1182/blood-2016-10-706465. Epub 2017 Jan 23.
10
EphA3 as a target for antibody immunotherapy in acute lymphoblastic leukemia.EphA3 作为急性淋巴细胞白血病抗体免疫治疗的靶点。
Leukemia. 2017 Aug;31(8):1779-1787. doi: 10.1038/leu.2016.371. Epub 2016 Dec 6.